Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Define the Effects of Decreasing the Furosemide Dose on Cardiorenal and Humoral Function in Humans With Compensated Chronic Heart Failure (CHF) With and Without Renal Dysfunction

NCT00982423 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00982423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00982423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Define the Effects of Decreasing the Furosemide Dose on Cardiorenal and Humoral Function in Humans With Compensated Chronic Heart Failure (CHF) With and Without Renal Dysfunction
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2009
Completion date
July 31, 2014
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, kidney dysfunction